Navigation Links
First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
Date:9/17/2007

's lives by pioneering novel healthcare solutions.

Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG (NYSE: NVS) -- a world leader in offering medicines to protect health, cure disease and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and enhance the quality of life. We are strengthening our medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high-quality and low-cost generics, human vaccines and leading self-medication OTC brands. Novartis is the only company with leadership positions in these areas. In 2006, the Group's businesses achieved net sales of USD 37.0 billion and net income of USD 7.2 billion. Approximately USD 5.4 billion was invested in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ more than 100,000 associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.

References

(1) Gardner, MJ, Brophy RH, Demetrakopoulos D, et al. Interventions to

improve osteoporosis treatment following hip fracture. Journal of

Bone and Joint Surgery. 2005; 87-A: 3-7.

(2) National Osteoporosis Foundation. About Osteoporosis: Fast Facts.

Available at: http://www.nof.org/osteoporosis/diseasefacts.htm

Accessed on August 31, 2007.

(3) Beatriz JE, Perry HM III. Age-related osteoporosis. Clin Geriatr Med.

1994; 10:575-587.

(4) Black D, Delmas, S,
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 2014  Savant HWP, Inc., a privately held ... human safety testing of 18-MC, an experimental treatment ... of 18-MC, administered as part of a double-blind, ... American partner, was well tolerated by healthy volunteers ... develop 18-MC as a treatment for many forms ...
(Date:9/23/2014)... , Sept. 23, 2014   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade hypothermic ... precision thermal shipping products for cells and ... additions to its Scientific Advisory Board.  The new members ... Davies , PhD. Dr. Acker is a ...
(Date:9/22/2014)... September 23, 2014 , ... authorities, increasing rigor for trial master file (TMF) accessibility ... largest TMF survey to date reveals an increase in ... provide auditors with remote access to their electronic trial ... surveyed in the Veeva 2014 Paperless TMF ...
Breaking Medicine Technology:Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy 2Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 2BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 4BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 5BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 6BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 7Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 2Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 3Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 4
... Va., Oct. 8 Mirixa Corporation, the leader ... hiring of Cheryl Hoffer as Vice President, Pharmacy ... Pharmacy Account Management team, supporting independent and chain ... The Pharmacy Account Management team also helps expand ...
... LAKE FOREST, Ill., Oct. 8 Hospira, Inc. (NYSE: ... pharmaceuticals, today signed a Business Cooperation Agreement with South ... outlines the business terms of a future distribution agreement ... Canada for eight biogeneric products that are currently under ...
Cached Medicine Technology:Mirixa Corporation Announces Key Pharmacy Network Hire 2Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs 2Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs 3
(Date:9/23/2014)... UT (PRWEB) September 23, 2014 Pricing ... addition of the following facilities. , 1. Prairie ... & Pain Institute is a nationally recognized leader in ... frequently presents both nationally and internationally on leading-edge, minimally ... experience using these techniques and quicker recovery times for ...
(Date:9/23/2014)... NC (PRWEB) September 23, 2014 Scarless ... open an 18,000 – square foot dermatology and vein ... a nationwide chain of dermatology centers. The center will ... training of healthcare professionals for the treatment of skin ... be led by Kamran Goudarzi, MD, a pioneer in ...
(Date:9/23/2014)... September 23, 2014 Recently, Best Cheap ... Bluehost and JustHost are the best VPS hosting suppliers ... make money from hosting, reseller hosting is a very ... allotted resources to host the others’ websites under his ... is very famous for two primary hosting plans (reseller ...
(Date:9/23/2014)... September 23, 2014 On September 9th, 2014, ... the most technically advanced horticultural LED grow light that they ... the XL750 and XL1000 , releasing a ... the experienced horticulturalist, because it has what the whole community ... Kind LED's grower-tested 12 band spectrum (also known as "the ...
(Date:9/23/2014)... September is Self-Improvement Month and the ... people improve their lives every day. This month long ... small to make improvements in their lives. The idea ... lives and make easy adjustments towards their goals. Whether ... or getting on track with finances, this month is ...
Breaking Medicine News(10 mins):Health News:PricingHealthcare.com Adds Pricing Data for Pittsburgh, New Orleans, Peoria Facilities 2Health News:Scarless VeinCare Partners with DemOne to Open State-of-the-Art Facility for Vein and Dermatology Care 2Health News:Scarless VeinCare Partners with DemOne to Open State-of-the-Art Facility for Vein and Dermatology Care 3Health News:Best Cheap Hosting USA: Bluehost And JustHost Are Ranked As The Best VPS Hosting Suppliers 2Health News:Kind LED K5 Series XL1000 Grow Lights Sell Out in Only 2 Days 2Health News:Emassagechair.com is Celebrating Self-Improvement Month by Giving Away a Foot Massager 2Health News:Emassagechair.com is Celebrating Self-Improvement Month by Giving Away a Foot Massager 3
... MONDAY, May 9 (HealthDay News) -- Overdiagnosis and overtreatment of ... to the large increase in the use of computed tomography ... embolism (PE) is a potentially life-threatening blood clot in the ... PE and its use has grown rapidly, according to background ...
... undergoing infertility treatment is stressful, with high rates of ... designed to help women reduce stress earlier in the ... is known specifically about the impact of these therapies ... A new study published June 1 in Fertility and ...
... - Nitric oxide gas appears to directly impact the ... cell disease, Georgia Health Sciences University researchers report. ... together, forming long chains that ultimately deform red blood ... vessels and pain, said Dr. C. Alvin Head, Chairman ...
... Week (DDW) is the largest international gathering of ... gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored ... Liver Diseases, the American Gastroenterological Association (AGA) Institute, ... Society for Surgery of the Alimentary Tract, DDW ...
... May 9 (HealthDay News) -- A new study finds that homosexual ... diagnosed with and then survive a cancer, shining a light on ... not the first time that researchers have noted differences in health ... higher risk of becoming infected with HIV, while lesbians may be ...
... By Amanda Gardner HealthDay Reporter , MONDAY, May ... any worse side effects than younger people experience, new research ... predictor for mortality or major adverse events, but it did ... B. Dorman, who is slated to present the findings Monday ...
Cached Medicine News:Health News:Scan Technology Tied to Overtreatment of Clots in Lungs 2Health News:Mind/body program increases pregnancy rates in IVF treatment 2Health News:Nitric oxide impacts source of sickle cell pain crisis 2Health News:UNC research highlights at 2011 Digestive Disease Week 2Health News:Gay Men More Likely to Have Had Cancer 2Health News:Weight-Loss Surgery Seems No Riskier for Seniors 2
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
... Sheet. Medpor Sheets are commonly used ... craniofacial applications. The thinner 0.4 mm ... surgeon with greater flexibility and to ... insertion into the orbit. It is ...
... precise punching of the donor corneal ... use with disposable trephine blades. Unique ... centration of the donor tissue. Recessed ... held centrally under the trephine blade. ...
... violet ink stands up ... scale ruler printed on ... quick measuring. Flexible, smudge-proof ... inch and metric scales. ...
Medicine Products: